CRVO CervoMed Forecast, Technical & Fundamental Analysis

a developer of pharmaceutical products

Industry Biotechnology

Get AI intraday signals

CRVO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CRVO
(Try 14 days for Free)

View a ticker or compare two or three

Compare

CRVO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CRVO
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

CRVO is expected to report earnings to rise 44.28% to -290 cents per share on August 21

Q2'23

Est.

$-2.90

Q1'23

Missed

by $0.10

Q4'22

Beat

by $0.22

Q3'22

Est.

$-2.06

Q2'22

Missed

by $1.05

The last earnings report on May 11 showed earnings per share of -200 cents, missing the estimate of -190 cents. With 9.44K shares outstanding, the current market capitalization sits at 103.58M.

A.I. Advisor

published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

20 Park Plaza

Phone

+1 617 744-4400

Employees

Web

https://www.cervomed.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
BNEFF	2.48	0.10	+4.20%
Bonterra Energy Corp.
REPYY	12.82	0.25	+1.99%
Repsol S.A.
SRNW	0.14	N/A	+0.14%
Stratos Renewables Corp.
DASTF	34.81	N/A	N/A
Dassault Systemes SA
ORKLY	9.39	-0.02	-0.21%
Orkla ASA

CRVO and Stocks

Correlation & Price change

A.I.dvisor tells us that CRVO and VIRX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRVO and VIRX's prices will move in lockstep.

Ticker / NAME	Correlation To CRVO	1D Price Change %
CRVO	100%	-2.03%
VIRX - CRVO	28% Poorly correlated	+4.35%
VKTX - CRVO	27% Poorly correlated	-13.37%
NKTR - CRVO	27% Poorly correlated	+8.94%
AVXL - CRVO	27% Poorly correlated	+6.66%
FATE - CRVO	25% Poorly correlated	+13.58%
More